
Anika: Record Revenue, Strong Margins, and Good News
If you only glance at Anika Therapeutics' second-quarter earnings, you might think it's just another financial report…look a little closer.

If you only glance at Anika Therapeutics' second-quarter earnings, you might think it's just another financial report…look a little closer.

It is with sadness that we publish this celebration of the life of Martin “Marty” Altshuler, one of the best known, loved and respected executives in the spine and orthopedic community.

A suspected cyberattack has triggered a severe global technology outage at Stryker Corporation.

VISIE announces the launch of a Partner API tool which allows any NAV or robotics system to seamlessly incorporate VISIE’s optical imaging system.

On a cold Midwestern morning in early 2026, a new venture fund is quietly sharpening its pencil.

The verdict against Medtronic, ordering damages in favor of rival Applied Medical Resources, is more than a high-stakes commercial dispute.

Augmedics announces that it is exiting the spine surgery market, an announcement that caught the entire industry by surprise. Why?

Remarkable 5-year cartilage repair outcomes reported at the ICRS World Congress in Boston.

Can AR NAV perform in extreme deformity cases (56° to 98° Cobb Angle)?

In this technology review, we highlight the latest advances in pediatric scoliosis care, specifically recent fusion-less correction advances. Check it out.

A miracle. For amputees and other disabled patients, that’s the effect of intelligent prosthetics, mobility, and reimbursement. For supplier Embla Medical, formerly Össur, it’s who they are and what they do. Here’s our profile.

Here’s the latest in the Prior Authorization fight, hiring among spine companies and the worrying rise in youth hockey injuries. Rough Cuts for the week of June 23rd.

Carlsmed, Inc. files to go “public” and raise $100 million. Goldman, Piper and Bank of America are leading. Will be a noteworthy deal, if successful. Here are the details.

“Move over Cold Dog, cause the Hot Dog’s moving in.” And “hot dog” is Visie’s spatial computing NAV camera. Takes surgical precision to logarithmically higher levels. Here are details.

Change is hard, but necessary. OrthoCarolina, which serves 1 million patients with 1,600 employees at 39 locations, literally transformed itself. Lessons here for all MSK service providers. Here’s the inside story.

AAOS’s members voted “YES” in record numbers to upgrade bylaws. Critics, notably Kevin Plancher, M.D., lost. Now…the hard work begins. Also, AMA sounds the alarm over physician health information.

More and more private practice Docs are throwing in the towel. Pay cuts. Increased costs and other burdens. Here are the numbers. Also ZBH finds a new gear and President. Here are details.

Highridge’s owner, H.I.G. Capital has sold its EBI business unit making Highridge a pure play spinal implant and instrument company. Here are the details.

Jean Dubousset dies at age 89. He and Cotrel made spine surgery a specialty in its own right. Physician payment versus inflation—3 guesses who is wining and the first two don’t count. Finally, how tormenting patients fuels payer profits.

Keven Plancher, M.D. sued AAOS when his nomination for Second Vice President didn’t make the cut. That was his first mistake. He then doubled down. Here are the “you can’t make this up” facts. It’s a disconcerting story.

AAOS MEMBERS: Your Critical Vote coming up. Get informed. Make an objective decision. SUPPORT your Academy and Society. Here is your GUIDE to the AAOS proposed Bylaws changes.

Albert DaCosta’s heartfelt note to colleagues and friends the day after his sale to Zimmer closed…was beautiful. We reprint it. Recession. Odds are it’s coming. Are you ready? We lay out what to expect.

It’s THE fight for the soul of science. Dr. Lucina Uddin, world renowned neuroscientist, sued ALL major journal publishers demanding they pay peer reviewers, stop coercing study authors, and stop violating anti-trust laws. Here’s the latest news.

Do robots and NAV make surgeons dumber? Unfortunately, there is no clear answer and it’s an ongoing debate among spine and ortho surgeons. What’s the evidence? We have some early studies.

Who is the highest paid Ortho CEO? No surprise, it’s Kevin Lobo, CEO of the highest sales and profit generating ortho company. But who is the most underpaid? And who was the target of a shareholder revolt? We have the surprising answers.

57-year-old Keith Valentine is Intrinsic Therapeutics new CEO! Which might surprise a lot of people. Valentine, who has helped build two-billion-dollar spine companies, could land anywhere. Why here? The answer might surprise. Basically, it’s what puts that smile on his face.

Time to batten down the hatches. This time next week, tariffs may have moderated and the reaction from trading partners may be negotiation not retaliation. But, while we expect the best, we prepare for the worst and take what comes.

Voting on the American Academy of Orthopaedic Surgeon’s (AAOS) proposal to streamline its bylaws begins in about a month—May 2025. Change, as we’ve noted in prior articles about AAOS, is difficult. And AAOS’s board is embarking on a long overdue updating of its bylaws. While AAOS has received strong support, it has also been on the receiving end of vigorous criticism.

Canary Medical CEO Bill Hunter is pioneering a new supplier business model which scales for an AI and Big Data future.

Thirty-eight teams entered the 2025 AAOS OrthoPitch contest hoping to emerge as the National Champion musculoskeletal.

Time to take a long hard look at non-metal constructs? We’re referring to PEKK, not PEEK. PEKK is antibacterial, a bio-mechanical twin to cortical bone, hypoallergenic, modifiable in the OR, and a friendlier implant than metal. Yes, it’s time.

A small study from a single site put allograft birth tissues to a notably challenging test—treating high energy (auto accident, explosion or gunshot) injuries where the bone and tissue damage is extensive, complex, and the incidence rate of infection or revision surgeries is above average. Allograft birth tissues deliver soft tissue coverage and a cocktail […]

The leading voice in orthopedics and spine reimagines its future while honoring its celebrated legacy

Your patient presents with pain and swelling in the knee. She says that her joint is stiff, and her range of motion has declined. Arthritis? She also tells you that the skin over her knee feels warm and tender. Her swollen knee is painful, and she tells you she is experiencing functional limitations in her […]

How will these decisions affect suppliers, hospitals, physicians and patients? Tariffs Bottom line—still early, but tariffs, at some level, are likely. Companies with manufacturing in Mexico and Canada are most vulnerable—like ConMed. “For Mexico and Canada, an additional 25% tariff on the total product value crossing the border into the United States, using our current […]

Nevro Corp., was founded in 2006, launched its first product in 2015, the HFX™ spinal cord stimulation (SCS) platform, which includes the Senza® SCS system to treat patients with back and leg pain. Over those nine development years, Nevro raised $153 million while losing money every year. Between 2015 and 2024, Nevro’s annual sales grew […]